FDA Approves Drospirenone Tablet for Pregnancy Prevention – APhA submits compounding comments to FDA. – (866) 348-2889.
Officials with the FDA have approved Exeltis’ drospirenone 4 mg (Slynd) oral tablet for pregnancy prevention, according to the company.
A progestin-only pill, this estrogen-free oral contraceptive is intended as a 24 active and 4 inactive tablet dosing regimen. The regimen also allows a 24-hour missed tablet window.
According to Exeltis, a division of Insud Pharma, this contraceptive tablet could be made available by Fall 2019.